COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

COVID-19 Briefings

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

CMS Releases Medicare Accelerated and Advance Payments Program Data

CMS maze of rules and regulations

New CMS data shows that clinical laboratories were among the top nonhospital beneficiaries of the Accelerated and Advance Payment (AAP) Program

Due to the COVID-19 pandemic and the fiscal effects that it inflicted on healthcare organizations, the US Centers for Medicare and Medicaid Services (CMS) made advanced Medicare payments available to most clinical entities using the Accelerated and Advance Payment (AAP) Program.

“In the throes of an unprecedented pandemic, providers and suppliers on the frontlines needed a lifeline to help keep them afloat,” said CMS Administrator Seema Verma. “CMS’ advanced payments were loans given to providers and suppliers to avoid having to close their doors and potentially causing a disruption in service for seniors.”

CMS has released, for the first time, data about these payments over the period up to Dec. 9, 2020. More than $107 billion has been paid out to healthcare providers over this timeframe. The data released by CMS breaks down how payments were distributed by type of provider and by the individual recipients of these funds. Clinical laboratories received $268,156,347, according to this new data and were among the top nonhospital recipients of the advance payments.

The data released by CMS is 1,449 pages long and includes the national provider identifier (NPI), provider/supplier name, and the payment amount for each recipient. Clinical laboratory leaders wishing to review these data or look up a specific entity can access this information here.

Related Resources: